This content is restricted.
Brief
"On February 6, 2025, Anvisa conducted a Public Hearing to discuss the revision of regulatory marks for registering and notifying phytotherapics. The report covers comments, questions, and responses from participants on Public Consultations (CP) 1290/2024, 1291/2024, 1292/2024, and 1293/2024, as well as contributions received in these consultations."
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested